Bhattacharyya B, Howard R, Maity S N, Brossi A, Sharma P N, Wolff J
Proc Natl Acad Sci U S A. 1986 Apr;83(7):2052-5. doi: 10.1073/pnas.83.7.2052.
Several properties of the colchicine-tubulin interaction such as association rate, reversibility, and the promotion of drug fluorescence have been related to the B ring of colchicine. The B ring itself retards the binding rate, and substitution at C-7 leads to further binding rate decreases that appear to be related to both substituent bulk and the presence of a N-acyl group. Thus, the decreasing order of binding rates is 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone greater than deacetamidocolchicine greater than deacetylcolchicine greater than or equal to colcemid greater than colchicine greater than N-benzoyldeacetylcolchicine, etc. The apparent irreversibility of the binding seems more closely related to the presence of an N-acyl group rather than the bulk of the substituent at C-7. Substitution at C-7 also affects the tropolone fluorophore. Thus, amines (deacetylcholchicine, colcemid, or N-methylcolcemid) fluoresce poorly in the presence of tubulin, whereas substitution of the amino group with an acyl group enhances fluorescence. The presence of an N-acyl group at C-7 is essential for enhanced fluorescence. We conclude that, in addition to A- and the C-ring portion of the molecule, the B ring of colchicine is a third determinant recognized by the binding site on tubulin.
秋水仙碱与微管蛋白相互作用的几个特性,如结合速率、可逆性以及药物荧光增强,都与秋水仙碱的B环有关。B环本身会降低结合速率,C-7位的取代会导致结合速率进一步降低,这似乎与取代基的体积以及N-酰基的存在都有关。因此,结合速率的递减顺序为:2-甲氧基-5-(2',3',4'-三甲氧基苯基)托酚酮>去乙酰氨基秋水仙碱>去乙酰秋水仙碱≥秋水仙酰胺≥秋水仙碱>N-苯甲酰基去乙酰秋水仙碱等。结合的明显不可逆性似乎与N-酰基的存在关系更为密切,而非C-7位取代基的体积。C-7位的取代也会影响托酚酮荧光团。因此,胺类(去乙酰秋水仙碱、秋水仙酰胺或N-甲基秋水仙酰胺)在微管蛋白存在时荧光较弱,而用酰基取代氨基则会增强荧光。C-7位存在N-酰基是荧光增强所必需的。我们得出结论,除了分子的A环和C环部分外,秋水仙碱的B环是微管蛋白结合位点识别的第三个决定因素。